Transfected Stable Cell Lines

Human KIF5B_RET (I788N) BAF3 Cell Line

  • For research use only

Cat No.

ABC-X0059C

Product Type

Overexpression Stable Cell Lines

Cell Type

Lymphocytes

Species

Human

Host Cell

BAF3

Source Organ

Lymphatic

Disease

Normal

Storage

Liquid Nitrogen

This engineered BAF3 cell line expressing KIF5B-RET (I788N) fusion enables functional study of RET mutations and testing of RET-targeted agents.

Product Image

Description

The Human KIF5B_RET (I788N) BAF3 Cell Line is a genetically engineered model derived from the murine pro-B cell line BAF3 based on customers’ requirement. This overexpression cell line is generated by stable integration of exogenous human KIF5B_RET (I788N) fusion gene into BAF3 host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT-PCR.
Target
The KIF5B_RET (I788N) fusion combines the motor protein KIF5B with the receptor tyrosine kinase RET, harboring the I788N mutation. This genetic alteration confers constitutive kinase activation, leading to aberrant cell growth and survival through MAPK and PI3K/AKT pathways. RET fusion events are recurrent in lung adenocarcinomas and thyroid cancers. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.

Species

Human

Cat.No

ABC-X0059C

Product Category

Transfected Stable Cell Lines

Size/Quantity

1 vial

Cell Type

Lymphocytes

Growth Mode

Suspension

Shipping Info

Dry Ice

Growth Conditions

37 °C, 5% CO2

Source Organ

Lymphatic

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Overexpression Stable Cell Lines

Host Cell

BAF3

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • The Human KIF5B_RET (I788N) BAF3 Cell Line provides a relevant model for dissecting RET fusion-driven oncogenesis and for evaluating selective RET inhibitors. This system supports drug screening, resistance mechanism analysis, and RET-targeted therapeutic development in solid tumor contexts.

Inquiring Human KIF5B_RET (I788N) BAF3 Cell Line

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button